These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24374329)

  • 1. Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study.
    Wali B; Ishrat T; Won S; Stein DG; Sayeed I
    Brain; 2014 Feb; 137(Pt 2):486-502. PubMed ID: 24374329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone in transient ischemic stroke: a dose-response study.
    Yousuf S; Atif F; Sayeed I; Tang H; Stein DG
    Psychopharmacology (Berl); 2014 Sep; 231(17):3313-23. PubMed ID: 24752655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone improves long-term functional and histological outcomes after permanent stroke in older rats.
    Wali B; Ishrat T; Stein DG; Sayeed I
    Behav Brain Res; 2016 May; 305():46-56. PubMed ID: 26921692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats.
    Ishrat T; Sayeed I; Atif F; Stein DG
    Brain Res; 2009 Feb; 1257():94-101. PubMed ID: 19135987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to improve post-stroke behavioral recovery in aged subjects.
    Buga AM; Bălşeanu A; Popa-Wagner A; Mogoantă L
    Rom J Morphol Embryol; 2009; 50(4):559-82. PubMed ID: 19942950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-stroke infections exacerbate ischemic brain injury in middle-aged rats: immunomodulation and neuroprotection by progesterone.
    Yousuf S; Atif F; Sayeed I; Wang J; Stein DG
    Neuroscience; 2013 Jun; 239():92-102. PubMed ID: 23079632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response, therapeutic time-window and tPA-combinatorial efficacy of compound 21: A randomized, blinded preclinical trial in a rat model of thromboembolic stroke.
    Ishrat T; Fouda AY; Pillai B; Eldahshan W; Ahmed H; Waller JL; Ergul A; Fagan SC
    J Cereb Blood Flow Metab; 2019 Aug; 39(8):1635-1647. PubMed ID: 29537907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the neurotherapeutic potential of a water-soluble progesterone analog after traumatic brain injury in rats.
    Wali B; Sayeed I; Guthrie DB; Natchus MG; Turan N; Liotta DC; Stein DG
    Neuropharmacology; 2016 Oct; 109():148-158. PubMed ID: 27267687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of therapeutic window of Cerebrolysin in embolic stroke: A prospective, randomized, blinded, and placebo-controlled study.
    Zhang L; Chopp M; Lu M; Zhang T; Li C; Winter S; Brandstaetter H; Doppler E; Meier D; Pabla P; Zhang ZG
    Int J Stroke; 2017 Aug; 12(6):628-635. PubMed ID: 28382851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
    Belayev L; Liu Y; Zhao W; Busto R; Ginsberg MD
    Stroke; 2001 Feb; 32(2):553-60. PubMed ID: 11157196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion.
    Marshall JW; Cummings RM; Bowes LJ; Ridley RM; Green AR
    Stroke; 2003 Sep; 34(9):2228-33. PubMed ID: 12920263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination treatment with low-dose Niaspan and tissue plasminogen activator provides neuroprotection after embolic stroke in rats.
    Shehadah A; Chen J; Cui Y; Zhang L; Roberts C; Lu M; Chopp M
    J Neurol Sci; 2011 Oct; 309(1-2):96-101. PubMed ID: 21802695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose estrogen treatment at reperfusion reduces lesion volume and accelerates recovery of sensorimotor function after experimental ischemic stroke.
    Carpenter RS; Iwuchukwu I; Hinkson CL; Reitz S; Lee W; Kukino A; Zhang A; Pike MM; Ardelt AA
    Brain Res; 2016 May; 1639():200-13. PubMed ID: 26995494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats.
    Xu L; Fagan SC; Waller JL; Edwards D; Borlongan CV; Zheng J; Hill WD; Feuerstein G; Hess DC
    BMC Neurol; 2004 Apr; 4():7. PubMed ID: 15109399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose GYKI-52466: prophylactic preconditioning confers long-term neuroprotection and functional recovery following hypoxic-ischaemic brain injury.
    Nayak PK; Kerr DS
    Neuroscience; 2013 Mar; 232():128-38. PubMed ID: 23246617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of progesterone following stroke in aged rats.
    Wang J; Jiang C; Liu C; Li X; Chen N; Hao Y
    Behav Brain Res; 2010 May; 209(1):119-22. PubMed ID: 20109497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
    Won S; Lee JH; Wali B; Stein DG; Sayeed I
    J Cereb Blood Flow Metab; 2014 Jan; 34(1):72-80. PubMed ID: 24045404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is a combination of progesterone and chloroquine more effective than either alone in the treatment of cerebral ischemic injury?
    Qin A; Zhang Q; Wang J; Sayeed I; Stein DG
    Restor Neurol Neurosci; 2019; 37(1):1-10. PubMed ID: 30741704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of SB-221420-A - a neuronal Ca(2+) and Na(+) channel antagonist in experimental models of stroke.
    Campbell CA; Barone FC; Benham CD; Hadingham SJ; Harries MH; Harling JD; Hills JM; Lewis VA; Mackay KB; Orlek BS; White RF; Parsons AA; Hunter AJ
    Eur J Pharmacol; 2000 Aug; 401(3):419-28. PubMed ID: 10936502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.